ICICI Direct has recommended a BUY rating on Narayana Hrudayalaya (NARHRU), a leading chain of multi-specialty hospitals, with a target price of Rs 1,485, representing a potential upside of 22% fro

Fortis Healthcare Ltd has announced that its board has approved the issuance of non-convertible debentures (NCDs) worth Rs 1,500 crore via private placement.

Chola Securities has issued a BUY recommendation for Narayana Hrudayalaya Limited (NHL), a leading healthcare provider, known for its expertise in cardiac, oncology, and nephrology treatments.

India’s beauty and personal care (BPC) market is experiencing rapid growth, driven by consumer trust, investor interest, and innovation.

Biognosys, a frontrunner in mass spectrometry-based proteomics, and Alamar Biosciences, Inc., a pioneer in precision proteomics for early disease detection, have forged a strategic alliance to prop

PolTREG SA, a Warsaw Stock Exchange listed pioneering clinical-stage biotechnology firm specializing in cellular therapies targeting autoimmune ailments, has disclosed pivotal findings in Internati